Moreover, the PD-related G2019S LRRK2 mutation stimulated CaV2.1 channels to a greater degree than the wild-type, supporting the hypothesis that LRRK2 mutations disrupt normal Ca2+ signaling in PD. This evidence concerns the gene LRRK2 and Parkinson disease.